In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.
Microsoft shipped ML.NET 3.0, enhancing deep learning and data processing scenarios in the company's machine language framework that lets devs create AI-infused apps completely within the .NET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results